ConfirmMDx Draft Medicare Coverage Policy Posted for Public Comment
June 20, 2014 02:00 ET
|
mdxhealth
IRVINE, California, and HERSTAL, BELGIUM - June 20, 2014 - MDxHealth SA (NYSE Euronext: MDXH), today announced that a draft coverage policy (Local Coverage Determination or LCD) for the ConfirmMDx®...
MDxHealth : déclaration de transparence d'un actionnaire
June 17, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, et HERSTAL, BELGIQUE, le 17 juin 2014 -MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour soutenir le...
MDxHealth Shareholder Transparency Notification
June 17, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, and HERSTAL, BELGIUM, June 17th, 2014 -MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer...
Assemblée Générale Ordinaire et Extraordinaire des actionnaires de MDxHealth
May 30, 2014 05:25 ET
|
mdxhealth
IRVINE, CA, et HERSTAL, BELGIQUE, le 30 mai 2014 -MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour soutenir le...
MDxHealth's Annual and Extraordinary General Shareholders' Meeting
May 30, 2014 05:25 ET
|
mdxhealth
IRVINE, CA, and HERSTAL, BELGIUM, 30 May, 2014 -MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer...
MDxHealth Reports 10-Fold Reduction of Repeat Prostate Biopsies in ConfirmMDx Clinical Utility Study
May 20, 2014 02:00 ET
|
mdxhealth
Results Published in American Health and Drug Benefits IRVINE, CA, and HERSTAL, BELGIUM - May 20, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and...
MDxHealth annonce des présentations sur ConfirmMDx for Prostate Cancer à la réunion annuelle 2014 de l'Association Américaine d'Urologie
May 15, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, et HERSTAL, BELGIQUE - le 15 mai 2014 - MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour améliorer le...
MDxHealth Announces Presentations on ConfirmMDx for Prostate Cancer at American Urological Association 2014 Annual Meeting
May 15, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, and HERSTAL, BELGIUM - May 15, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the...
MDxHealth et American Pathology Partners annoncent un accord de commercialisation du test ConfirmMDx for Prostate Cancer
May 13, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, et LIEGE, BELGIQUE - le 13 mai 2014 - MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour améliorer le...
MDxHealth and American Pathology Partners Announce Marketing Agreement for ConfirmMDx for Prostate Cancer
May 13, 2014 02:00 ET
|
mdxhealth
IRVINE, CA, and LIEGE, BELGIUM - May 13, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis...